Marketed by
GENPLUS PHARMA & SURGICALS
Contains
Saker T is a Ceftriaxone and Tazobactam powerful antibiotic combination used to treat various severe bacterial infections. It contains Ceftriaxone, a broad-spectrum cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor. This dual-action formulation effectively targets infections of the urinary tract, respiratory system, skin, bones, joints, blood, and brain. Ceftriaxone destroys bacteria by disrupting cell wall synthesis, while Tazobactam enhances its efficacy by neutralizing bacterial resistance enzymes. Saker T is also administered for post-surgical infection prevention, pneumonia, sepsis, and typhoid fever management. It is not effective against viral infections.
ISO & GMP
High Quality Products
Top Manufacturing
Saker T Injection is a powerful combination therapy used to treat a wide range of serious bacterial infections. Ceftriaxone, a broad-spectrum antibiotic, targets both aerobic and anaerobic, gram-positive and gram-negative bacteria by disrupting the formation of the bacterial cell wall, leading to cell death. Tazobactum, a beta-lactamase inhibitor, works synergistically by protecting ceftriaxone from enzymatic degradation, thereby enhancing its antibacterial efficacy and reducing the risk of resistance. This combination makes TAZOX highly effective in managing complex and resistant infections.